Collateral Resistance of a Dideoxycytidine-Resistant Cell Line to 5-Fluoro-2′-deoxyuridine
Open Access
- 7 September 1999
- journal article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 262 (3) , 657-660
- https://doi.org/10.1006/bbrc.1999.1270
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Comparison of 5-fluoro-2′-deoxyuridine with 5-fluorouracil and their role in the treatment of colorectal cancerEuropean Journal Of Cancer, 1998
- 2′,3′-Dideoxycytidine induced drug resistance in human cellsLife Sciences, 1995
- Antiviral therapy for human immunodeficiency virus infectionsClinical Microbiology Reviews, 1995
- Isolation and characterization of a human ileocecal carcinoma cell line (HCT-8) subclone resistant to fluorodeoxyuridineBiochemical Pharmacology, 1993
- Generation of drug-resistant variants of human immunodeficiency virus type 1 by in vitro passage in increasing concentrations of 2',3'-dideoxycytidine and 2',3'-dideoxy-3'-thiacytidineAntimicrobial Agents and Chemotherapy, 1993
- Kinetic Analysis of 5‐Fluorouracil Action against Various Cancer CellsJapanese Journal of Cancer Research, 1990
- The in vitro and in vivo anti-retrovirus activity, and intracellular metabolism of 3′-azido-2′,3′-dideoxythymidine and 2′,3′-dideoxycytidine are highly dependent on the cell speciesBiochemical Pharmacology, 1988
- Resistance of CCRF-CEM cloned sublines to 5-fluorodeoxyuridine associated with enhanced phosphatase activitiesBiochemical Pharmacology, 1985
- Fluorinated pyrimidines as tight-binding inhibitors of thymidylate synthetasePharmacology & Therapeutics, 1981
- Resistance of Mammalian Tumour Cells toward Pyrimidine AnaloguesOncology, 1973